Smoltek Nanotech Holding AB (XSAT:SMOL)
Sweden · Delayed Price · Currency is SEK 0.5360
+0.0200 (3.88%)
At close: Mar 18, 2026
XSAT:SMOL Revenue
In the year 2025, Smoltek Nanotech Holding AB had annual revenue of 4.20M SEK, down -18.22%. Smoltek Nanotech Holding AB had revenue of 1.55M in the quarter ending December 31, 2025, with 82.44% growth.
Revenue
4.20M
Revenue Growth
-18.22%
P/S Ratio
23.08
Revenue / Employee
233.22K
Employees
18
Market Cap
96.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.20M | -935.04K | -18.22% |
| Dec 31, 2024 | 5.13M | -7.58M | -59.62% |
| Dec 31, 2023 | 12.71M | 5.03M | 65.55% |
| Dec 31, 2022 | 7.68M | 1.82M | 31.11% |
| Dec 31, 2021 | 5.86M | -1.05M | -15.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Gullberg & Jansson AB | 270.61M |
| SolidX AB | 143.51M |
| QBNK Holding AB | 41.24M |
| Redsense Medical AB | 26.80M |
| Touchtech AB | 22.42M |
| Genetic Analysis AS | 19.36M |
| AcuCort AB | 6.68M |
| Biofrigas Sweden AB | 1.50M |